Immunophenotyping in a COVID-19 Cohort (IMPACC) Transcriptomics and Genotyping Assays

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

IMPACC group, A. Ozonoff, J. Schaenman, et al.. (2022). eBioMedicine. Cited 57 times. https://doi.org/10.1016/j.ebiom.2022.104208

Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study

Nadine Rouphael, H. Maecker, Ruth R. Montgomery, et al.. (2021). Science Immunology. Cited 45 times. https://doi.org/10.1126/sciimmunol.abf3733

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

Al Ozonoff, N. Jayavelu, Shanshan Liu, et al.. (2024). Nature Communications. Cited 45 times. https://doi.org/10.1038/s41467-023-44090-5

Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

J. Diray-Arce, S. Fourati, N. Jayavelu, et al.. (2023). Cell Reports Medicine. Cited 39 times. https://doi.org/10.1016/j.xcrm.2023.101079

Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality

Jeremy P. Gygi, Cole P. Maguire, Ravi K. Patel, et al.. (2024). The Journal of Clinical Investigation. Cited 20 times. https://doi.org/10.1172/JCI176640